Long‐term treatment of older patients with overactive bladder using a combination of mirabegron and solifenacin: a prespecified analysis from the randomized, phase III SYNERGY II study

AIMS: SYNERGY II was a 12‐month phase III trial in patients with overactive bladder (OAB) symptoms that investigated the safety and efficacy of the combination of mirabegron and solifenacin in comparison with each monotherapy. This analysis evaluated the trial findings using four age subgroups (<...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurourol Urodyn
Main Authors: Mueller, Elizabeth R., van Maanen, Rob, Chapple, Christopher, Abrams, Paul, Herschorn, Sender, Robinson, Dudley, Stoelzel, Matthias, Yoon, Sang J., Al‐Shukri, Salman, Rechberger, Tomasz, Gratzke, Christian
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Original Clinical Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6850571/
https://ncbi.nlm.nih.gov/pubmed/30644570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/nau.23919
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados